PharmTech Europe News

AbbVie Gains Nod from NICE for Tepkinly

February 04, 2024

NICE has recommended the use of AbbVie's Tepkinly as a treatment option for eligible adults with diffuse large B-cell lymphoma.

Latest Acquisition Sees ProductLife Group Expand its Asia-Pacific Footprint

February 03, 2024

ProductLife Group has announced its acquisition of Australian company Commercial Eyes.

EMA Given Grant to Support Establishment of African Medicines Agency

February 02, 2024

The agency will coordinate intra-regional medicines regulation to strengthen the African regulatory network.

Lonza and Oxford Nanopore Partner on mRNA Analytics

February 02, 2024

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

MHRA’s New International Recognition Procedure

February 02, 2024

The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.

Agilent and Incyte Collaborate on Development of CDx in Hematology and Oncology

February 02, 2024

Agilent Technologies and Incyte have signed an agreement to collaborate on the development of companion diagnostics programs.

Europa Perspectives—Pan-European Challenges and Solutions Post Brexit

February 01, 2024

An interview with Steffen Thirstrup, chief medical officer, European Medicines Agency (EMA).

IMU Biosciences Raises Millions in Series A Funding Round

January 30, 2024

IMU Biosciences has secured £11.5 million in its Series A financing round.

Getinge Brings Chemistry and Instrument Decontamination Under One Roof

January 26, 2024

Getinge has announced the inauguration of its new Global Centre of Excellence for Chemistry in the United Kingdom

Pharmapack Report Points to Inhaled Pulmonary and Intranasal Drug Delivery as Areas to Watch

January 26, 2024

The annual industry report of the Pharmapack Europe event suggests there will be significant innovation in inhaled pulmonary and intranasal drug delivery in 2024.